Cervical Cancer “Miracle” Drug Generates Glimmer Of Hope For Women

Women with advanced cervical cancer – the most common cancer afflicting young women – are to get the first officially approved new treatment for a decade.Trials show Avastin, which is used in several other cancers, gives women around four months’ extra life. The drug plus chemotherapy has now been licensed by European regulators.Patients will have access via the Cancer Drugs Fund (CDF) until it is considered for routine NHS use. It has been available in England via the CDF since last March pending licensing.

Each year an estimated 600 women with advanced cervical cancer could benefit from Avastin, costing £3,370 for a month’s treatment.The drug’s use was accelerated by the US Food and Drug Administration which approved Avastin plus chemotherapy for advanced cervical cancer in August 2020.

Prev1 of 2
Continue Reading on Next Page